Back
Corcept Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
CORT
Corcept Therapeutics, Inc.
Last Price:
$42.47
Seasonality Move:
5.41%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
Corcept Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.17 | Buy |
| 20-day SMA: | 35.72 | Buy |
| 50-day SMA: | 37.86 | Buy |
| 200-day SMA: | 63.42 | Sell |
| 8-day EMA: | 39.4 | Buy |
| 20-day EMA: | 37.41 | Buy |
| 50-day EMA: | 40.31 | Buy |
| 200-day EMA: | 55.89 | Sell |
Corcept Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.95 | Buy |
| Relative Strength Index (14 RSI): | 65.79 | Buy |
| Chaikin Money Flow: | 585121 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 38.63) | Buy |
| Bollinger Bands (100): | (32.01 - 73.89) | Sell |
Corcept Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics, Inc. Stock
Is Corcept Therapeutics, Inc. Stock a Buy?
-
Corcept Therapeutics, Inc. share price is 42.49 while CORT 8-day simple moving average is 39.17, which is a Buy signal.
-
The stock price of CORT is 42.49 while Corcept Therapeutics, Inc. 20-day SMA is 35.72, which makes it a Buy.
-
Corcept Therapeutics, Inc. 50-day simple moving average is 37.86 while CORT share price is 42.49, making it a Buy technically.
-
CORT stock price is 42.49 and Corcept Therapeutics, Inc. 200-day simple moving average is 63.42, creating a Sell signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
62
Corcept Therapeutics, Inc. (CORT)
is a Buy
Is Corcept Therapeutics, Inc. a Buy or a Sell?
-
Corcept Therapeutics, Inc. stock is rated a BuyThe current Corcept Therapeutics, Inc. [CORT] share price is $42.49. The Score for CORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics, Inc. Stock Info
Market Cap:
4.6B
Price in USD:
42.49
Share Volume:
1.5M
Corcept Therapeutics, Inc. 52-Week Range
52-Week High:
91.00
52-Week Low:
28.66
Buy
62
Corcept Therapeutics, Inc. (CORT)
is a Buy
Corcept Therapeutics, Inc. Share Price Forecast
-
What is the Corcept Therapeutics, Inc. stock price today?The Corcept Therapeutics, Inc. stock price is 42.49 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics, Inc. is not overvalued.
Is Corcept Therapeutics, Inc. Stock a Buy?
-
Corcept Therapeutics, Inc. share price is 42.49 while CORT 8-day exponential moving average is 39.40, which is a Buy signal.
-
The stock price of CORT is 42.49 while Corcept Therapeutics, Inc. 20-day EMA is 37.41, which makes it a Buy.
-
Corcept Therapeutics, Inc. 50-day exponential moving average is 40.31 while CORT share price is 42.49, making it a Buy technically.
-
CORT stock price is 42.49 and Corcept Therapeutics, Inc. 200-day simple moving average is 55.89, creating a Sell signal.
Fundamental Analysis of Corcept Therapeutics, Inc.
Is Corcept Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.17 per share, a decrease this year of $0.55 per share, and an increase next year of $1.20 per share.
Technical Analysis of Corcept Therapeutics, Inc.
Should I short Corcept Therapeutics, Inc. stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 0.95, suggesting Corcept Therapeutics, Inc. is a Buy
-
Corcept Therapeutics, Inc. Relative Strength Index (RSI) is 65.79, which suggest Corcept Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics, Inc. is (32.65 - 38.63), which suggest Corcept Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Corcept Therapeutics, Inc. is (32.01 - 73.89), which suggest Corcept Therapeutics, Inc. is a Sell
* Corcept Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.